PBLS

Conviction 100HealthcareScan · Thu, Sep 24, 2026

Parabilis Medicines, Inc. (PBLS) closed at $32.43 (-2.64%) on Sep 24, 2026. Price is below its 50-day. RSI(14) 38, -22.3% from its 52-week high, +2.6% year to date. Sector: Healthcare · Biotechnology.

PBLS$32.43-2.64%

ResistanceSupportVol 14Insider buy

Vol MA14 1.53M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Parabilis Medicines, Inc.Biotechnologywww.parabilismed.com ↗

Price32.43

Change-2.64%

Gap+1.22%

Rel volume2.94×

Avg volume1.2M

Avg $ vol46.22M

SMA 2038.11

SMA 5036.12

SMA 200—

Price vs 50-10.23%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 41.74

RSI (14)38

MACD hist-0.76

MACD cross—

Stoch %K / %D12 / 20

ADX (14)24

+DI / −DI15 / 27

RSI divergenceBearish

MACD divergence—

ATR %9.23%

ADR %7.27%

52w high41.73

52w low25.01

From 52w high-22.29%

Above 52w low+29.67%

New 52w highNo

SqueezeOff

Bollinger width25.47%

%B-0.08

Donchian pos11.91%

Donchian high42.49

Donchian low31.07

AVWAP (52w high)38.48

vs AVWAP high-15.71%

AVWAP (52w low)34.09

vs AVWAP low-4.87%

OBV trendUp

Chaikin MF (20)0.14

Today vs 20d2.94×

Avg vol (14d)1.53M

Avg vol (20d)1.2M

Avg $ vol (20d)46.22M

Market cap3.95B

RS Rating—

RS 3m (vs SPY)+18.54%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank14.7

1 week-20.67%

1 month-17.33%

3 months+23.03%

6 months—

1 year—

YTD+2.63%

P/E—

P/B3.77

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.01

Current17.91

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target41.75

Target upside28.74%

Analyst ratingBuy

Institutional77.12%

Ent. value2.87B

Revenue148K

Net income-52.46M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out117.17M

Employees—

ListedWed, Jun 10, 2026

Free float82.07M

Float %67.3%

Short interest5.52M

Days to cover14.2d

Short volume80.0%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$2.13 vs −$0.16

Last surprise-1231.3% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank14.7 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance41.99

Support35.01

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PBLS

All disclosures →

No recent disclosed trades by Congress in PBLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PBLS · open-market 8 buys

Insider	Side	Shares	Value	Traded	Filed
Tendler Craig Director · Stock Option (Right to Buy) · 2026-08-22	Grant	20.29K	—	2026-08-22	2026-08-25
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-22	Buy	47.25K	$1.4M	2026-07-22	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-21	Buy	6.5K	$190K	2026-07-21	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-21	Buy	37.72K	$1.1M	2026-07-21	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-21	Buy	21.7K	$607K	2026-07-21	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-20	Buy	32.99K	$914K	2026-07-20	2026-07-22
RA CAPITAL MANAGEMENT, L.P. Director · Voting Common Stock · 2026-07-20	Buy	98.43K	$2.7M	2026-07-20	2026-07-22
Levy Guy 10% owner · Series F Preferred Stock · 2026-06-11	Convert	527.07K	—	2026-06-11	2026-06-29
Levy Guy 10% owner · Common Stock, par value $0.0001 per share · 2026-06-11	Buy	375K	$7.5M	2026-06-11	2026-06-29
Levy Guy 10% owner · Common Stock, par value $0.0001 per share · 2026-06-11	Buy	125K	$2.5M	2026-06-11	2026-06-29

SEC filings

EDGAR filings in PBLS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.